For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows.

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, ...

Life expectancy in the United States increased in 2023, reaching 78.4 years, while drug overdose mortality decreased from 2022 to 2023.

More men with limited life expectancy and certain localized prostate cancers have received definitive treatment over the past ...

The following editorial appeared in The Wall Street Journal. It does not necessarily reflect the opinion of The Tribune- Democrat.

Life expectancy in 2023 rose 0.9 years to 78.4 while the overall mortality rate adjusted for age declined 6%. Death rates ...

"Life expectancy in the U.S. last year made an unusually sharp increase as deaths from most major causes declined, according ...

Diabetes and prediabetes were significantly associated with decreased life expectancy and increased ... Cox regression analysis models to calculate adjusted mortality rate ratios (RRs).

The COVID-19 pandemic triggered a massive surge in mortality in the U.S., resulting in reduced life expectancy. But today ... rebounds in 2022 and 2023 are thanks to declines in the age-adjusted death ...